Vi Ngo, PA-C
Physician Assistant · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Vi Ngo’s office at (408) 847-6191 to ask if they take your plan before you enroll.
California Medical Board record
Licence A55899 · Current
Licensed to practise in California · since 1996 · expires 2028-01-31 · University of Western Ontario Faculty of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$358,702
Pharmacies billed $358,702 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
477 generic and fewer than 11 brand-name prescriptions · $358,702 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tagrisso | 13 | $220,225 | $16,940 |
| Eliquis | 31 | $26,919 | $868 |
| Imatinib Mesylate | 26 | $5,587 | $215 |
| Anastrozole | 123 | $3,115 | $25 |
| Hydroxyurea | 51 | $2,070 | $41 |
See all 14 drugs
| Tagrisso | 13 | $220,225 | $16,940 |
| Eliquis | 31 | $26,919 | $868 |
| Imatinib Mesylate | 26 | $5,587 | $215 |
| Anastrozole | 123 | $3,115 | $25 |
| Hydroxyurea | 51 | $2,070 | $41 |
| Anagrelide | 19 | $2,060 | $108 |
| Letrozole | 33 | $998 | $30 |
| Deferasirox | 11 | $924 | $84 |
| Folic Acid | 49 | $678 | $14 |
| Ondansetron | 19 | $404 | $21 |
| Ondansetron Odt | 11 | $231 | $21 |
| Allopurinol | 17 | $166 | $10 |
| Alendronate | 39 | $128 | $3 |
| Prednisone | 11 | $37 | $3 |
Year by year
| 2024 | 533 | 119 | None | None | $358,702 |
| 2023 | 404 | 118 | None | 14% | $338,158 |
| 2022 | 300 | 84 | None | None | $165,369 |
| 2021 | 236 | 115 | 8% (19) | None | $5,674 |
| 2020 | 112 | 79 | 11% (12) | None | $1,623 |
| 2019 | 80 | 59 | 15% (12) | None | $1,560 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Imatinib Mesylate | 30 | $76,764 | $2,559 |
| Eliquis | 19 | $15,106 | $795 |
| Anagrelide | 23 | $8,433 | $367 |
| Anastrozole | 102 | $5,816 | $57 |
| Letrozole | 33 | $2,066 | $63 |
| Hydroxyurea | 30 | $1,814 | $60 |
| Ondansetron | 20 | $681 | $34 |
| Allopurinol | 16 | $169 | $11 |
| Folic Acid | 22 | $159 | $7 |
2022: 10 drugs
| Imatinib Mesylate | 20 | $86,458 | $4,323 |
| Eliquis | 12 | $8,649 | $721 |
| Anastrozole | 56 | $2,507 | $45 |
| Anagrelide | 24 | $1,634 | $68 |
| Hydroxyurea | 19 | $1,153 | $61 |
| Letrozole | 22 | $821 | $37 |
| Ondansetron | 13 | $568 | $44 |
| Raloxifene | 11 | $428 | $39 |
| Ondansetron Odt | 18 | $268 | $15 |
| Folic Acid | 29 | $187 | $6 |
2021: 6 drugs
| Hydroxyurea | 23 | $1,779 | $77 |
| Anastrozole | 43 | $1,071 | $25 |
| Ondansetron Odt | 22 | $468 | $21 |
| Letrozole | 12 | $204 | $17 |
| Cephalexin | 11 | $81 | $7 |
| Hydrocodone-Acetaminophen | 15 | $50 | $3 |
2020: 3 drugs
| Cephalexin | 12 | $71 | $6 |
| Naproxen | 12 | $50 | $4 |
| Ibuprofen | 11 | $40 | $4 |
2019: 1 drug
| Ondansetron Odt | 11 | $72 | $7 |
Money from drug and device companies
$1,484 in 2025
| 2025 | 27 | 59 | None | $1,484 |
| 2024 | 25 | 73 | None | $1,721 |
| 2023 | 27 | 77 | None | $2,042 |
| 2022 | 23 | 105 | None | $2,408 |
| 2021 | 9 | 38 | None | $1,101 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Lynparza | $284 | 10 payments
|
| Janssen Biotech | Erleada | $139 | 6 payments
|
| GlaxoSmithKline | Jemperli | $132 | 2 payments
|
| Pfizer | Elrexfio | $117 | 4 payments
|
| Iovance Biotherapeutics | Amtagvi | $82 | 3 payments
|
| Lilly USA | Verzenio | $79 | 3 payments
|
See all 56 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-18 | None | $22 |
| Janssen Biotech | Meals · 2025-12-17 | Rybrevant | $32 |
| Genzyme | Meals · 2025-12-05 | Wayrilz | $27 |
| Agios Pharmaceuticals | Meals · 2025-11-21 | Pyrukynd | $29 |
| Janssen Biotech | Meals · 2025-11-17 | Erleada | $37 |
| Iovance Biotherapeutics | Meals · 2025-11-14 | Amtagvi | $25 |
| Sobi | Meals · 2025-10-30 | Vonjo | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-28 | Tagrisso | $25 |
| Janssen Biotech | Meals · 2025-10-16 | Rybrevant | $22 |
| Aveo Pharmaceuticals | Meals · 2025-10-15 | Fotivda | $22 |
| Progenics Pharmaceuticals | Meals · 2025-10-10 | Pylarify | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-03 | None | $33 |
| Agios Pharmaceuticals | Meals · 2025-10-02 | Pyrukynd | $32 |
| Merck Sharp & Dohme | Meals · 2025-09-24 | Keytruda | $17 |
| GlaxoSmithKline | Meals · 2025-09-11 | Jemperli | $14 |
| GlaxoSmithKline | Meals · 2025-09-10 | Jemperli | $118 |
| Pfizer | Meals · 2025-09-05 | Ibrance | $38 |
| PharmaEssentia USA | Meals · 2025-08-27 | Besremi | $25 |
| Pfizer | Meals · 2025-08-08 | Elrexfio | $30 |
| Genmab U.S. | Meals · 2025-07-29 | Epkinly | $29 |
| Incyte | Meals · 2025-07-23 | Monjuvi | $19 |
| Iovance Biotherapeutics | Meals · 2025-07-18 | Amtagvi | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-11 | Opdivo | $23 |
| Lilly USA | Meals · 2025-07-09 | Verzenio | $32 |
| Daiichi Sankyo | Meals · 2025-07-03 | Datroway | $14 |
| Janssen Biotech | Meals · 2025-06-27 | Erleada | $9 |
| Merck Sharp & Dohme | Meals · 2025-06-25 | Keytruda | $22 |
| Janssen Biotech | Meals · 2025-06-13 | Erleada | $29 |
| Legend Biotech USA | Meals · 2025-06-12 | Carvykti | $16 |
| Taiho Oncology | Meals · 2025-06-10 | Lonsurf | $28 |
| Jazz Pharmaceuticals | Meals · 2025-06-04 | Ziihera | $39 |
| Daiichi Sankyo | Meals · 2025-05-30 | Enhertu | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-29 | None | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-28 | None | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-22 | Imfinzi | $26 |
| Pfizer | Meals · 2025-05-16 | Ibrance | $19 |
| Pfizer | Meals · 2025-05-15 | Elrexfio | $29 |
| Novartis Pharmaceuticals | Meals · 2025-05-13 | Lutathera | $28 |
| Progenics Pharmaceuticals | Meals · 2025-05-09 | Pylarify | $19 |
| Caris MPI | Meals · 2025-05-08 | Mi Cancer Seek | $25 |
| Eisai | Meals · 2025-04-17 | Lenvima | $19 |
| Iovance Biotherapeutics | Meals · 2025-04-16 | Amtagvi | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-28 | Enhertu | $27 |
| Janssen Biotech | Meals · 2025-03-24 | Erleada | $9 |
| Kite Pharma | Meals · 2025-03-22 | Yescarta | $23 |
| Coherus Oncology | Meals · 2025-03-20 | Loqtorzi | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-10 | None | $14 |
| Lilly USA | Meals · 2025-03-03 | Verzenio | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-27 | Lynparza | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-21 | Imfinzi | $14 |
| Eisai | Meals · 2025-02-03 | Lenvima | $14 |
| Pharmacosmos Therapeutics | Meals · 2025-01-29 | Monoferric | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-24 | Lynparza | $38 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-15 | Tagrisso | $35 |
| Novocure | Meals · 2025-01-14 | Optune Lua (Novottf-200t) | $19 |
| Lilly USA | Meals · 2025-01-10 | Verzenio | $19 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,721
| Janssen Biotech | Erleada | $225 | 11 payments
|
| Pfizer | Elrexfio | $207 | 11 payments
|
| Aveo Pharmaceuticals | Fotivda | $177 | 4 payments
|
| Novartis Pharmaceuticals | Pluvicto | $152 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $109 | 5 payments
|
| Coherus Biosciences | Udenyca | $91 | 3 payments
|
| Progenics Pharmaceuticals | Pylarify | $86 | 3 payments
|
| Astellas Pharma US | Xtandi | $77 | 3 payments
|
| Exelixis | Cabometyx | $66 | 2 payments
|
| Lilly USA | Verzenio | $61 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $56 | 2 payments
|
| Abbvie | Epkinly | $52 | 2 payments
|
| Eisai | Lenvima | $48 | 2 payments
|
| Celgene | Reblozyl | $41 | 2 payments
|
| Mirati Therapeutics | Krazati | $38 | 2 payments
|
| Daiichi Sankyo | Enhertu | $35 | 2 payments
|
| Rigel Pharmaceuticals | Rezlidhia | $35 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $30 | 1 payment
|
| Accord Healthcare | Camcevi | $25 | 1 payment
|
| Pharmacosmos Therapeutics | Monoferric | $21 | 1 payment
|
| Taiho Oncology | Lonsurf | $21 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $20 | 1 payment
|
| Incyte | Jakafi | $19 | 1 payment
|
| Servier Pharmaceuticals | Oncaspar | $16 | 1 payment
|
| Octapharma USA | Octagam Immune Globulin (Human) | $15 | 1 payment
|
2023: $2,042
| Seagen | Adcetris | $286 | 7 payments
|
| Janssen Biotech | Erleada | $261 | 8 payments
|
| Amgen | Evenity | $156 | 6 payments
|
| Progenics Pharmaceuticals | Pylarify | $145 | 6 payments
|
| Exelixis | Cabometyx | $116 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $101 | 4 payments
|
| Lilly USA | Verzenio | $98 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $89 | 3 payments
|
| Novartis Pharmaceuticals | Pluvicto | $74 | 4 payments
|
| Eisai | Lenvima | $70 | 3 payments
|
| Coherus Biosciences | Udenyca | $67 | 2 payments
|
| Incyte | Jakafi | $60 | 3 payments
|
| AVEO Pharmaceuticals | Fotivda | $53 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $52 | 2 payments
|
| PharmaEssentia USA | Besremi | $49 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $46 | 2 payments
|
| Celgene | Pomalyst | $46 | 2 payments
|
| Rigel Pharmaceuticals | Rezlidhia | $43 | 3 payments
|
| Daiichi Sankyo | Enhertu | $41 | 2 payments
|
| Mirati Therapeutics | Krazati | $35 | 2 payments
|
| Jazz Pharmaceuticals | Zepzelca | $33 | 1 payment
|
| Amneal Pharmaceuticals | Avastin | $30 | 1 payment
|
| Genentech USA | Xolair | $22 | 1 payment
|
| Astellas Pharma US | Xtandi | $22 | 1 payment
|
| CTI BioPharma | Vonjo | $16 | 1 payment
|
| ADC Therapeutics America | None | $16 | 1 payment
|
| Pharmacosmos Therapeutics | Monoferric | $16 | 1 payment
|
2022: $2,408
| AstraZeneca Pharmaceuticals LP | Enhertu | $328 | 15 payments
|
| Janssen Biotech | Erleada | $278 | 10 payments
|
| Amgen | Lumakras | $259 | 10 payments
|
| Lilly USA | Verzenio | $248 | 10 payments
|
| Coherus Biosciences | Udenyca | $239 | 8 payments
|
| Seagen | Adcetris | $221 | 6 payments
|
| Novartis Pharmaceuticals | Kisqali | $158 | 8 payments
|
| Merck Sharp & Dohme | Keytruda | $85 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $81 | 3 payments
|
| Progenics Pharmaceuticals | Pylarify | $78 | 3 payments
|
| AVEO Pharmaceuticals | Fotivda | $57 | 3 payments
|
| Celgene | Pomalyst | $54 | 3 payments
|
| Rigel Pharmaceuticals | Tavalisse | $48 | 3 payments
|
| Eisai | Lenvima | $46 | 2 payments
|
| Astellas Pharma US | Padcev | $45 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $37 | 2 payments
|
| Acrotech Biopharma | Folotyn | $27 | 1 payment
|
| Pfizer | Inlyta | $24 | 1 payment
|
| Kite Pharma | None | $23 | 1 payment
|
| Incyte | Monjuvi | $20 | 1 payment
|
| Epizyme | Tazverik | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $17 | 1 payment
|
| Mylan Institutional | None | $17 | 1 payment
|
2021: $1,101
| Amgen | Nplate | $253 | 8 payments
|
| Pfizer | Ibrance | $214 | 10 payments
|
| Janssen Biotech | Erleada | $156 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $152 | 4 payments
|
| Lilly USA | Verzenio | $137 | 6 payments
|
| Seagen | Adcetris | $96 | 2 payments
|
| Novartis Pharmaceuticals | Kisqali | $46 | 2 payments
|
| Karyopharm Therapeutics | Xpovio | $26 | 1 payment
|
| Eisai | Lenvima | $22 | 1 payment
|
Professional record
- NPI
- 1104307305
- Licence
- CA 55899California A55899: Current · expires 2028-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 9460 N Name Uno Ste 230, Gilroy, CA, 95020
- NPI first listed
- 2018-08-24
- NPI last updated
- 2024-03-04
- NPI record certified
- 2024-03-04
This is when the NPI record was last certified, not a medical board exam.